ARRDC3
Arrestin domain-containing protein 3
Also known as: ARRD3_HUMAN, KIAA1376, TLIMP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96B67
- Gene
- ARRDC3
- Ensembl
- ENSG00000113369
- Chromosome
- 5
- Canonical length
- 414 aa
- Protein class
- Predicted intracellular proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of the arrestin family of proteins, which regulate G protein-mediated signaling. The encoded protein is thought to act as a regulator of breast cancer growth and progression by binding to a phosphorylated form of integrin beta4, a tumor-related antigen, targeting the integrin for internalization and degradation. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
414 residues, UniProt reviewed canonical sequence.
>Q96B67|ARRDC3
1 MVLGKVKSLT ISFDCLNDSN VPVYSSGDTV SGRVNLEVTG EIRVKSLKIH ARGHAKVRWT
61 ESRNAGSNTA YTQNYTEEVE YFNHKDILIG HERDDDNSEE GFHTIHSGRH EYAFSFELPQ
121 TPLATSFEGR HGSVRYWVKA ELHRPWLLPV KLKKEFTVFE HIDINTPSLL SPQAGTKEKT
181 LCCWFCTSGP ISLSAKIERK GYTPGESIQI FAEIENCSSR MVVPKAAIYQ TQAFYAKGKM
241 KEVKQLVANL RGESLSSGKT ETWNGKLLKI PPVSPSILDC SIIRVEYSLM VYVDIPGAMD
301 LFLNLPLVIG TIPLHPFGSR TSSVSSQCSM NMNWLSLSLP ERPEAPPSYA EVVTEEQRRN
361 NLAPVSACDD FERALQGPLF AYIQEFRFLP PPLYSEIDPN PDQSADDRPS CPSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARRDC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 158 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 158 nTPM
- breast: 89 nTPM
- thyroid gland: 79 nTPM
- adrenal gland: 76 nTPM
- placenta: 72 nTPM
- liver: 71 nTPM
Single-cell type
- adrenal cortex cells: 501 nCPM
- pancreatic acinar cells: 484 nCPM
- syncytiotrophoblasts: 455 nCPM
- neutrophils: 247 nCPM
- hepatocytes: 236 nCPM
- lacrimal acinar cells: 217 nCPM
Immune cell
- neutrophil: 116 nTPM
- naive CD8 T-cell: 38 nTPM
- gdT-cell: 29 nTPM
- basophil: 29 nTPM
- naive CD4 T-cell: 24 nTPM
- memory CD8 T-cell: 23 nTPM
Brain region
- white matter: 77 nTPM
- medulla oblongata: 53 nTPM
- choroid plexus: 44 nTPM
- spinal cord: 44 nTPM
- cerebellum: 43 nTPM
- basal ganglia: 40 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.87
- DepMap mean gene effect
- 0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fat pad development
- heat generation
- negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway
- negative regulation of cold-induced thermogenesis
- negative regulation of locomotion involved in locomotory behavior
- positive regulation of hippo signaling
- positive regulation of ubiquitin-protein transferase activity
- protein transport
- skin development
- negative regulation of heat generation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARRDC3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARRDC3 as an antibody target. Whether an autoantibody or antibody against ARRDC3 could matter depends on whether native ARRDC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARRDC3 is annotated at the cell surface, where native ARRDC3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ARRDC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...